*Poor monsoon will be first big challenge for new govt: CLSA
*FII inflows into India unlikely to pickup in next few weeks: Quant
*Apollo Hospitals a buy, stock can double in 3 yrs: Merrill
*Bullish on mkt on 5 year basis; buy IT, pharma: Raamdeo
*See GDP growth at 5.6% in FY15, maintains India Ratings
*Brace for some correction in run-up to May 16: UR Bhat
*HUL Q4 beats estimates; net rises 11%, volume growth at 3%
*IDEA CELLULAR 4Q ARPU 173 RUPEES VS 169 RUPEES IN 3Q
*IDEA CELLULAR 4Q NET 5.9B RUPEES; EST. 5.24B
*Godrej Consumer Q4 net down 29.28% at Rs 236.28cr
*Bajaj Corp Q4 net down 22% at Rs 38.31 cr
*Shree Cement Jan-Mar quarter net profit down 19% to Rs 222 cr
*Gartner pegs Indian public cloud services market at $557 mn in 2014
*South Africa lobbying to host BRICS Development Bank
*Ambuja Cements, ACC extend weakness post March quarter results
*Divestment programme shall be back on track: Pranav Haldea
*DB Realty tanks 5%, ED names Balwa in 2G scam chargesheet
*Move over SoBo; Navi Mumbai is new hotspot in commercial realty
*YES Bank’s stance on Madhu Kapur dims hope for out-of-court settlement
*REC to raise up to Rs 30,000 cr via debentures
*Natco’s US partner files ANDA for chemotherapy drug
*Muthoot’s CSR initiative extended to 3 more districts in Kerala
*Vantage Circle raises Rs 1.20 crore from angel investors
*Etihad set to escape open offer for Jet
*CBRE projects 4-5 lakh job opportunities in big cities in 2yrs
*Fire accident at Shasun Pharma’s Pondicherry API facility
*Synechron to invest $35 million for development centres in India
*Pfizer chasing AstraZeneca in potential $100 billion-plus deal
*Wal-Mart paid USD 334 m to end India partnership
*Confident of clocking 30% revenue growth in FY15: CERA
*Markets end lower amid weak Asian cues; BHEL & Hero weak, Wipro gains 2%
*Himachal regulator lifts ban on Wockhardt drug
*RCom, Tata Tele, Aircel tie up for 3G services
